Gene · 7175
Papers1,702
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,702
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of a CHIP isogenic human iPSC-derived cortical neuron model for functional proteomics. | STAR Protoc | 2022 | 35391935 | PubTator, text mining | PubMed |
| DNA circles promote yeast ageing in part through stimulating the reorganization of nuclear pore complexes. | Elife | 2022 | 35373738 | PubTator, text mining | PubMed |
| NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance. | Front Oncol | 2022 | 35372074 | PubTator, text mining | PubMed |
| Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease. | J Biol Chem | 2022 | 35367208 | PubTator, text mining | PubMed |
| ZFC3H1 and U1-70K promote the nuclear retention of mRNAs with 5' splice site motifs within nuclear speckles. | RNA | 2022 | 35351812 | PubTator, text mining | PubMed |
| Correction: Phosphorylation of nucleoporin Tpr governs its differential localization and is required for its mitotic function. | J Cell Sci | 2022 | 35344051 | PubTator, text mining | PubMed |
| Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. | Eur J Endocrinol | 2022 | 35333737 | PubTator, text mining | PubMed |
| The Challenge and Opportunity of NTRK Inhibitors in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2022 | 35328336 | PubTator, text mining | PubMed |
| Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study. | Diagnostics (Basel) | 2022 | 35328252 | PubTator, text mining | PubMed |
| Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort. | Diagnostics (Basel) | 2022 | 35328221 | PubTator, text mining | PubMed |
| MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis. | Cancers (Basel) | 2022 | 35326531 | PubTator, text mining | PubMed |
| A systems radiation biology approach to unravel the role of chronic low-dose-rate gamma-irradiation in inducing premature senescence in endothelial cells. | PLoS One | 2022 | 35286349 | PubTator, text mining | PubMed |
| Case Report: Patient With Lung Adenocarcinoma With ALK-HLA-DRB1 Rearrangement Shows Impressive Progression-Free Survival After Sequential Crizotinib and Ceritinib Treatment. | Front Oncol | 2022 | 35280798 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Quantitative Proteomics Reveals Molecular Network Driving Stromal Cell Differentiation: Implications for Corneal Wound Healing. | Int J Mol Sci | 2022 | 35269714 | PubTator, text mining | PubMed |
| Multi-Platform-Based Analysis Characterizes Molecular Alterations of the Nucleus in Human Colorectal Cancer. | Front Cell Dev Biol | 2022 | 35265610 | PubTator, text mining | PubMed |
| Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer. | PLoS Comput Biol | 2022 | 35263321 | PubTator, text mining | PubMed |
| Nup98 Is Subverted from Annulate Lamellae by Hepatitis C Virus Core Protein to Foster Viral Assembly. | mBio | 2022 | 35258330 | PubTator, text mining | PubMed |
| Gene Expression Regulation in Airway Pathogens: Importance for Otitis Media. | Front Cell Infect Microbiol | 2022 | 35252035 | PubTator, text mining | PubMed |
| High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. | Front Immunol | 2022 | 35242139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7175/papers?page=21